PROTAGENIC THERAPEUTICS INC C/WTS 26/04/2026 (TO PUR COM) (PTIXW)
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.0035
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 0.0740
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- Unusual Whales · 1 day ago, 12:02 PM
Nature Methods Publication Reveals Deep Insights into Functional Biology through First-of-its-Kind Quantification of Tau Proteoforms
- TradingView · Sep 2 at 09:13 PM
PMGC Holdings Amends YuvaBio Development and License Deal to Launch Three-Phase Expansion Program
- benzinga_article · Sep 2 at 02:53 PM
Telix Pharmaceuticals shares are trading higher after HC Wainwright & Co. reiterated its Buy rating on the stock and maintained a $20 price target.
- Unusual Whales · Sep 1 at 11:46 AM
NorthStrive Biosciences Expands AI-Driven Drug Discovery Program with Yuva Biosciences, Advancing Four Novel AI-Discovered Compounds Toward Lead Nomination for Potential Cardiac Disease and Obesity Therapeutic Applications
- Earnings Watch · Nov 26, 2025 at 10:29 PM
PROTAGENIC THERAPEUTICS INC C/WTS 26/04/2026 (TO PUR COM) | 10-Q: FY2026 Q2 Revenue: USD 0
- Earnings Watch · May 13, 2025 at 07:23 PM
PROTAGENIC THERAPEUTICS INC C/WTS 26/04/2026 (TO PUR COM) | 10-Q: FY2025 Q1 EPS: USD -2.75
